Lumos Pharma: Q4 Earnings Insights
Lumos Pharma: Q4 Earnings Insights
Lumos Pharma (NASDAQ:LUMO) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:05 PM.
Lumos Pharma（納斯達克股票代碼：LUMO）於2024年3月7日星期四下午4點05分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Lumos Pharma missed estimated earnings by -2.0%, reporting an EPS of $-1.17 versus an estimate of $-1.15.
Lumos Pharma報告每股收益爲-1.17美元，未達到預期收益-2.0％，而預期爲-1.15美元。
Revenue was up $314 thousand from the same period last year.
收入比去年同期增長了31.4萬美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.11 which was followed by a 11.0% increase in the share price the next day.
上個季度，該公司的每股收益高出0.11美元，隨後第二天股價上漲了11.0％。
Here's a look at Lumos Pharma's past performance:
以下是Lumos Pharma過去的表現：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.15 | -1.10 | -1.12 | -0.93 |
| EPS Actual | -1.04 | -1.09 | -0.89 | -0.98 |
| Revenue Estimate | 320K | 410K | 180K | 110K |
| Revenue Actual | 7K | 527K | 691K | 512K |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -1.15 | -1.10 | -1.12 | -0.93 |
| 實際每股收益 | -1.04 | -1.09 | -0.89 | -0.98 |
| 收入估算 | 320K | 410K | 180K | 110K |
| 實際收入 | 7K | 527K | 691K | 512K |
To track all earnings releases for Lumos Pharma visit their earnings calendar here.
要追蹤Lumos Pharma的所有業績，請在此處訪問其業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。